Lupin, headquartered in Mumbai, India, is a global pharmaceutical player with products distributed in over 100 markets ...

Pharma company Lupin Ltd announced on Wednesday that it has received the Establishment Inspection Report (EIR) from the ...

Lupin today announced that it has received the Establishment Inspection Report (EIR) from the United States Food and Drug Administration (U.S. FDA) for its Pithampur Unit-1 manufacturing facility that ...

Lupin shares continue to rise, trading at a new 52-week high of Rs 2,376 after a 15% return over two weeks. The Nifty Pharma ...

An analyst from Master Capital Trust said that Reliance is witnessing a strong bullish setup on the monthly chart as prices ...

Nilesh Gupta, Managing Director of Lupin, emphasised that this acquisition aligns with the company’s commitment to expanding ...

The drug is indicated for the treatment of HIV-1 infection and for pre-exposure prophylaxis to reduce the risk of HIV-1 ...

Global pharma major Lupin Limited announced today the acquisition of Huminsulin® in India from Eli Lilly and Company to ...

Lupin strengthens its diabetes portfolio with the acquisition of Huminsulin products from Eli Lilly, including Insulin Human ...

Lupin Ltd. acquires Huminsulin range from Eli Lilly, strengthening its position in the Indian diabetes market.